News Briefs CMP Therapeutics By PE Hub Staff - 27 October 2006 Share A- A+ 100% CMP Therapeutics Ltd., an Oxford, UK-based developer of treatments for such conditions as asthma and hay fever, has closed its Series A funding with Share this:TwitterLinkedIn
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.